Drugs / VC005 tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05997927 | Jul 2023 → Jul 2024 | atopic eczema | Jiangsu vcare pharmaceutical technology co., LTD | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VC005 tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05997927 ↗ |